Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Zydus Lifesciences Limited Call Transcript 2020

Mar 20, 2020

59059_rns_2020-03-20_e40c7b39-0fb0-496d-9815-15381e3b9f58.pdf

Call Transcript

Open in viewer

Opens in your device viewer

BSELiitedm haNiolStkEofIndiatnaocaxcnge
1sFltP.J.Tooor,wers limited
DalalStetre h5thaPlFlExcngeaza,oor,
bai-400M001um C/1PllockBotNoG,,
Band-Kla{Et)plCSandraurraasomex,
bai-400051Mum
KindAttn.: olhaISanjGMr.ecay KindAttn.: chFaPoaramroze
GalkrishnMr.opan PridViAtsstesence
Code: 532321 Sbol:ym CADILAHC
MchDatear: 202020,
Sub.ScheduleofAldIn'lltsto:anverscanays

Dear Sir / Madam

Pursuant to regulation 30 of the SEBI [Listing Obligations and Disclosure Requirements] Regulations, 2015, we hereby inform that the Company has planned Analyst and Investors' conference call on March 20, 2020 at 3:00 p.m., to explain the impact of COVID-19 on the business. Axis Capital Limited is the facilitator for this call. The Call details are attached herewith.

Thanking you,

Yours faithfully, For, CADILA HEALTHCARE LIMITED

C,,ll'va? --

DHAVAL N. SONI COMPANY SECRETARY

Encl.: As above.

Axis House, C-2, Wadia International Centre, P.B Marg. Worli, Mumbai 400 025 (India)

Cadila Healthcare

Conference Call on 20 th March 2020 hosted by Axis Capital Limited

We are pleased to host, on behalf of Axis Bank, a conference call for investors on Friday, 20 th March, 2020 at 3:00 – 3:30 PM IST to discuss the impact of Covid-19. Please note that call will be restricted to the potential impact of Coronavirus and update on hydroxychloroquine (HCQS).

The call will be initiated with a brief management discussion on current ground level situation, followed by an interactive Question & Answer session. The company will be represented by

Mr. Sharvil Patel : Managing Director
Mr. Nitin Parekh : CFO
Mr. Vishal Gor : IR Head

Details of the conference call are:

Date Friday, 20th March2020
Time 3:00 - 3:30 PM IST 05:30 PM HK/SG 9:30 AM London Time 05:30 AM New York
Call Leader Mr. Prakash Agarwal, Axis Capital
Country Dial in numbers
Primary number +91 22 6280 1145 / + 91 22 7115 8046
India Local +91 7045671221 (Available all over India)
International Dial In
- Hong Kong 800 964 448
- Singapore 800 101 2045
- U K 0 808 101 1573
- USA 1 866 746 2133

For further information please contact:

Prakash Agarwal

Dy Head - Research Institutional Equity Research Axis Capital Limited Direct: +91 22 4325 1145 Board: +91 22 4325 2525 Mobile: +91 9820534334 Email: [email protected]